Difference Of Opinion Suggests There Could Be A Possible Meridia Recall In U.S. Before The FDA Holds Its Public Advisory Meeting In September 2010
read more »
16 Comments Add this link to... Bury
16 Comments Add this link to... Bury
Bristol-Myers Squibb is joining the world community in providing immediate help for survivors of the massive earthquake that struck Haiti on January 12. The company has already shipped a large donati
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Patients in Japan will benefit from the approval of three new Novartis medicines - Equa® (vildagliptin), marketed as Galvus® in the European Union, for the treatment of type 2 diabetes, Exforge® (val
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
In the face of the unprecedented earthquake that hit the island of Haiti, sanofi-aventis has committed 1 million Euros in financial aid to long-term reconstruction initiatives and the rehabilitation
read more »
1 Comment Add this link to... Bury
1 Comment Add this link to... Bury
Will Send Email Alerts To Healthcare Providers When Dangerous Or Life-Threatening Prescription Drug Errors Are Reported To ISMP
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
State Senate Republicans Move In January 2010 To Delay, Again, Any Action Regarding This "FDA Defense" Law
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Posted by
worldpharmanews
21 days ago
(http://www.worldpharmanews.com)
Category: Conferences & Events |
Health 2.0 Europe, known for its live demos, will assemble speakers from 12 European countries and the U.S., in order to explain the world of Web 2.0 (both computer an read more »
Discuss Add this link to... Bury
Posted by
worldpharmanews
25 days ago
(http://www.worldpharmanews.com)
Category: Research & Development |
Discuss Add this link to... Bury
This COPD Medication Had Previously Been Possibly Linked To Stroke, Heart Attack, And Death
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Genzyme Corp. (NASDAQ: GENZ) reported that preliminary fourth-quarter revenue was $1.08 billion, compared with $1.17 billion in the same period in 2008. For the year, revenue was $4.5 billion compare
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
